{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "SINO BIOPHARM", "longName": "Sino Biopharmaceutical Limited", "messageBoardId": "finmb_7654965", "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "market": "hk_market", "esgPopulated": false, "regularMarketChangePercent": -2.1791804, "regularMarketPrice": 4.04, "marketState": "CLOSED", "fiftyTwoWeekHighChangePercent": -0.2504638, "fiftyTwoWeekLow": 3.58, "fiftyTwoWeekHigh": 5.39, "earningsTimestamp": 1680260340, "earningsTimestampStart": 1680260340, "earningsTimestampEnd": 1680260340, "trailingAnnualDividendRate": 0.106, "trailingPE": 28.857143, "trailingAnnualDividendYield": 0.025665859, "epsTrailingTwelveMonths": 0.14, "epsForward": 0.25, "epsCurrentYear": 0.22, "priceEpsCurrentYear": 18.363636, "sharesOutstanding": 18809200640, "bookValue": 1.611, "fiftyDayAverage": 4.3086, "fiftyDayAverageChange": -0.2686, "fiftyDayAverageChangePercent": -0.062340435, "twoHundredDayAverage": 4.30485, "twoHundredDayAverageChange": -0.26485014, "twoHundredDayAverageChangePercent": -0.06152366, "marketCap": 76730507264, "forwardPE": 16.16, "priceToBook": 2.5077593, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 3, "regularMarketChange": -0.09000015, "regularMarketTime": 1683878916, "regularMarketDayHigh": 4.14, "regularMarketDayRange": "4.03 - 4.14", "regularMarketDayLow": 4.03, "regularMarketVolume": 32167802, "regularMarketPreviousClose": 4.13, "bid": 4.04, "ask": 4.05, "bidSize": 0, "askSize": 0, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 4.12, "averageDailyVolume3Month": 36926669, "averageDailyVolume10Day": 24143106, "fiftyTwoWeekLowChange": 0.46000004, "fiftyTwoWeekLowChangePercent": 0.12849164, "fiftyTwoWeekRange": "3.58 - 5.39", "fiftyTwoWeekHighChange": -1.3499999, "firstTradeDateMilliseconds": 1084325400000, "symbol": "1177.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Unit 09, Office Tower", "address2": "41st Floor, Room 4109 Convention Plaza 1 Harbour Road", "city": "Wan Chai", "country": "Hong Kong", "phone": "852 2802 9886", "fax": "852 2880 0847", "website": "https://www.sinobiopharm.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.", "fullTimeEmployees": 26272, "companyOfficers": [{"maxAge": 1, "name": "Ms. Y. Y.  Tse", "age": 30, "title": "Exec. Chairwoman of the Board", "yearBorn": 1992, "fiscalYear": 2021, "totalPay": {"raw": 5068474, "fmt": "5.07M", "longFmt": "5,068,474"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eric S. Y.  Tse", "age": 26, "title": "CEO & Exec. Director", "yearBorn": 1996, "fiscalYear": 2021, "totalPay": {"raw": 3331944, "fmt": "3.33M", "longFmt": "3,331,944"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ping  Tse", "age": 70, "title": "Founder & Sr. Exec. Vice Chairman", "yearBorn": 1952, "fiscalYear": 2021, "totalPay": {"raw": 6048636, "fmt": "6.05M", "longFmt": "6,048,636"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cheung Ling  Cheng", "age": 58, "title": "Exec. Vice Chairwoman of the Board", "yearBorn": 1964, "fiscalYear": 2021, "totalPay": {"raw": 4266078, "fmt": "4.27M", "longFmt": "4,266,078"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Mingqin  Li", "age": 63, "title": "Sr. VP & Exec. Director", "yearBorn": 1959, "fiscalYear": 2021, "totalPay": {"raw": 173148, "fmt": "173.15k", "longFmt": "173,148"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Zhoushan  Tian", "age": 58, "title": "Exec. Director", "yearBorn": 1964, "fiscalYear": 2021, "totalPay": {"raw": 261742, "fmt": "261.74k", "longFmt": "261,742"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hsin  Tse", "age": 52, "title": "Sr. VP & Exec. Director", "yearBorn": 1970, "fiscalYear": 2021, "totalPay": {"raw": 841643, "fmt": "841.64k", "longFmt": "841,643"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Chun Ling  Li", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sean  Chen", "title": "Chief Strategy Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Orphanides  George", "title": "Chief Scientific Advisor of invoX", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 1, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}